nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—Progesterone—uterine cancer	0.215	0.296	CbGbCtD
Dihydrocodeine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.206	0.284	CbGbCtD
Dihydrocodeine—CYP3A4—Progesterone—uterine cancer	0.137	0.188	CbGbCtD
Dihydrocodeine—CYP2D6—Doxorubicin—uterine cancer	0.0656	0.0903	CbGbCtD
Dihydrocodeine—CYP3A4—Etoposide—uterine cancer	0.0612	0.0842	CbGbCtD
Dihydrocodeine—CYP3A4—Doxorubicin—uterine cancer	0.0417	0.0574	CbGbCtD
Dihydrocodeine—Hepatic enzyme increased—Progesterone—uterine cancer	0.00731	0.0267	CcSEcCtD
Dihydrocodeine—Affect lability—Progesterone—uterine cancer	0.00494	0.018	CcSEcCtD
Dihydrocodeine—Mood swings—Progesterone—uterine cancer	0.00475	0.0174	CcSEcCtD
Dihydrocodeine—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.00447	0.0164	CcSEcCtD
Dihydrocodeine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00432	0.0158	CcSEcCtD
Dihydrocodeine—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.00431	0.0157	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Progesterone—uterine cancer	0.00366	0.0134	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Progesterone—uterine cancer	0.00343	0.0125	CcSEcCtD
Dihydrocodeine—Urethral disorder—Progesterone—uterine cancer	0.0034	0.0124	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00331	0.0121	CcSEcCtD
Dihydrocodeine—Angiopathy—Progesterone—uterine cancer	0.00315	0.0115	CcSEcCtD
Dihydrocodeine—Immune system disorder—Progesterone—uterine cancer	0.00313	0.0115	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Progesterone—uterine cancer	0.00313	0.0114	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00311	0.0114	CcSEcCtD
Dihydrocodeine—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00308	0.0113	CcSEcCtD
Dihydrocodeine—Mental disorder—Progesterone—uterine cancer	0.00304	0.0111	CcSEcCtD
Dihydrocodeine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00285	0.0104	CcSEcCtD
Dihydrocodeine—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.0104	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00283	0.0104	CcSEcCtD
Dihydrocodeine—Angioedema—Progesterone—uterine cancer	0.00276	0.0101	CcSEcCtD
Dihydrocodeine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00276	0.0101	CcSEcCtD
Dihydrocodeine—Vertigo—Progesterone—uterine cancer	0.00271	0.00992	CcSEcCtD
Dihydrocodeine—Convulsion—Progesterone—uterine cancer	0.00262	0.00957	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00255	0.00934	CcSEcCtD
Dihydrocodeine—Dry mouth—Progesterone—uterine cancer	0.00252	0.00919	CcSEcCtD
Dihydrocodeine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.0025	0.00914	CcSEcCtD
Dihydrocodeine—Confusional state—Progesterone—uterine cancer	0.00249	0.00909	CcSEcCtD
Dihydrocodeine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00246	0.00899	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Progesterone—uterine cancer	0.00242	0.00884	CcSEcCtD
Dihydrocodeine—Skin disorder—Progesterone—uterine cancer	0.00239	0.00875	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Progesterone—uterine cancer	0.00238	0.00871	CcSEcCtD
Dihydrocodeine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00237	0.00867	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00231	0.00846	CcSEcCtD
Dihydrocodeine—Hypotension—Progesterone—uterine cancer	0.0023	0.00842	CcSEcCtD
Dihydrocodeine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00833	CcSEcCtD
Dihydrocodeine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.00823	CcSEcCtD
Dihydrocodeine—Paraesthesia—Progesterone—uterine cancer	0.00221	0.00809	CcSEcCtD
Dihydrocodeine—Dyspnoea—Progesterone—uterine cancer	0.0022	0.00804	CcSEcCtD
Dihydrocodeine—Somnolence—Progesterone—uterine cancer	0.00219	0.00801	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00801	CcSEcCtD
Dihydrocodeine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00793	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.0079	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00213	0.00778	CcSEcCtD
Dihydrocodeine—Constipation—Progesterone—uterine cancer	0.00211	0.00771	CcSEcCtD
Dihydrocodeine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.00763	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Progesterone—uterine cancer	0.00203	0.00743	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Progesterone—uterine cancer	0.00202	0.00737	CcSEcCtD
Dihydrocodeine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00201	0.00733	CcSEcCtD
Dihydrocodeine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00199	0.00728	CcSEcCtD
Dihydrocodeine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00199	0.00726	CcSEcCtD
Dihydrocodeine—Urticaria—Progesterone—uterine cancer	0.00196	0.00716	CcSEcCtD
Dihydrocodeine—Abdominal pain—Progesterone—uterine cancer	0.00195	0.00712	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00705	CcSEcCtD
Dihydrocodeine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00698	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Etoposide—uterine cancer	0.00187	0.00684	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00673	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00668	CcSEcCtD
Dihydrocodeine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00649	CcSEcCtD
Dihydrocodeine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00646	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Etoposide—uterine cancer	0.00175	0.00641	CcSEcCtD
Dihydrocodeine—Pruritus—Progesterone—uterine cancer	0.00174	0.00638	CcSEcCtD
Dihydrocodeine—Urethral disorder—Etoposide—uterine cancer	0.00174	0.00636	CcSEcCtD
Dihydrocodeine—Diarrhoea—Progesterone—uterine cancer	0.00169	0.00617	CcSEcCtD
Dihydrocodeine—Dizziness—Progesterone—uterine cancer	0.00163	0.00596	CcSEcCtD
Dihydrocodeine—Angiopathy—Etoposide—uterine cancer	0.00161	0.00589	CcSEcCtD
Dihydrocodeine—Immune system disorder—Etoposide—uterine cancer	0.0016	0.00586	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Etoposide—uterine cancer	0.0016	0.00585	CcSEcCtD
Dihydrocodeine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00578	CcSEcCtD
Dihydrocodeine—Vomiting—Progesterone—uterine cancer	0.00157	0.00573	CcSEcCtD
Dihydrocodeine—Rash—Progesterone—uterine cancer	0.00155	0.00568	CcSEcCtD
Dihydrocodeine—Dermatitis—Progesterone—uterine cancer	0.00155	0.00568	CcSEcCtD
Dihydrocodeine—Headache—Progesterone—uterine cancer	0.00154	0.00565	CcSEcCtD
Dihydrocodeine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00559	CcSEcCtD
Dihydrocodeine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0054	CcSEcCtD
Dihydrocodeine—Nausea—Progesterone—uterine cancer	0.00146	0.00535	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Dactinomycin—uterine cancer	0.00144	0.00525	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00143	0.00521	CcSEcCtD
Dihydrocodeine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00519	CcSEcCtD
Dihydrocodeine—Affect lability—Epirubicin—uterine cancer	0.00142	0.00518	CcSEcCtD
Dihydrocodeine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00515	CcSEcCtD
Dihydrocodeine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00514	CcSEcCtD
Dihydrocodeine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00512	CcSEcCtD
Dihydrocodeine—Vertigo—Etoposide—uterine cancer	0.00139	0.00508	CcSEcCtD
Dihydrocodeine—Abdominal pain—Dactinomycin—uterine cancer	0.00138	0.00504	CcSEcCtD
Dihydrocodeine—Mood swings—Epirubicin—uterine cancer	0.00136	0.00498	CcSEcCtD
Dihydrocodeine—Convulsion—Etoposide—uterine cancer	0.00134	0.00489	CcSEcCtD
Dihydrocodeine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00485	CcSEcCtD
Dihydrocodeine—Affect lability—Doxorubicin—uterine cancer	0.00131	0.00479	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00131	0.00478	CcSEcCtD
Dihydrocodeine—Confusional state—Etoposide—uterine cancer	0.00127	0.00465	CcSEcCtD
Dihydrocodeine—Mood swings—Doxorubicin—uterine cancer	0.00126	0.00461	CcSEcCtD
Dihydrocodeine—Skin disorder—Etoposide—uterine cancer	0.00123	0.00448	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Etoposide—uterine cancer	0.00122	0.00446	CcSEcCtD
Dihydrocodeine—Diarrhoea—Dactinomycin—uterine cancer	0.00119	0.00436	CcSEcCtD
Dihydrocodeine—Hypotension—Etoposide—uterine cancer	0.00118	0.00431	CcSEcCtD
Dihydrocodeine—Paraesthesia—Etoposide—uterine cancer	0.00113	0.00414	CcSEcCtD
Dihydrocodeine—Dyspnoea—Etoposide—uterine cancer	0.00112	0.00411	CcSEcCtD
Dihydrocodeine—Somnolence—Etoposide—uterine cancer	0.00112	0.0041	CcSEcCtD
Dihydrocodeine—Vomiting—Dactinomycin—uterine cancer	0.00111	0.00405	CcSEcCtD
Dihydrocodeine—Rash—Dactinomycin—uterine cancer	0.0011	0.00402	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00109	0.00398	CcSEcCtD
Dihydrocodeine—Constipation—Etoposide—uterine cancer	0.00108	0.00394	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Epirubicin—uterine cancer	0.00105	0.00383	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Etoposide—uterine cancer	0.00104	0.0038	CcSEcCtD
Dihydrocodeine—Nausea—Dactinomycin—uterine cancer	0.00104	0.00378	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Etoposide—uterine cancer	0.00103	0.00377	CcSEcCtD
Dihydrocodeine—Urticaria—Etoposide—uterine cancer	0.001	0.00366	CcSEcCtD
Dihydrocodeine—Abdominal pain—Etoposide—uterine cancer	0.000997	0.00364	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Epirubicin—uterine cancer	0.000983	0.00359	CcSEcCtD
Dihydrocodeine—Urethral disorder—Epirubicin—uterine cancer	0.000976	0.00357	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00097	0.00355	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000909	0.00332	CcSEcCtD
Dihydrocodeine—Angiopathy—Epirubicin—uterine cancer	0.000903	0.0033	CcSEcCtD
Dihydrocodeine—Urethral disorder—Doxorubicin—uterine cancer	0.000903	0.0033	CcSEcCtD
Dihydrocodeine—Immune system disorder—Epirubicin—uterine cancer	0.000899	0.00329	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Epirubicin—uterine cancer	0.000897	0.00328	CcSEcCtD
Dihydrocodeine—Pruritus—Etoposide—uterine cancer	0.000892	0.00326	CcSEcCtD
Dihydrocodeine—Mental disorder—Epirubicin—uterine cancer	0.000872	0.00319	CcSEcCtD
Dihydrocodeine—Diarrhoea—Etoposide—uterine cancer	0.000863	0.00315	CcSEcCtD
Dihydrocodeine—Angiopathy—Doxorubicin—uterine cancer	0.000835	0.00305	CcSEcCtD
Dihydrocodeine—Dizziness—Etoposide—uterine cancer	0.000834	0.00305	CcSEcCtD
Dihydrocodeine—Immune system disorder—Doxorubicin—uterine cancer	0.000832	0.00304	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Doxorubicin—uterine cancer	0.00083	0.00303	CcSEcCtD
Dihydrocodeine—Mental disorder—Doxorubicin—uterine cancer	0.000807	0.00295	CcSEcCtD
Dihydrocodeine—Vomiting—Etoposide—uterine cancer	0.000802	0.00293	CcSEcCtD
Dihydrocodeine—Rash—Etoposide—uterine cancer	0.000795	0.00291	CcSEcCtD
Dihydrocodeine—Dermatitis—Etoposide—uterine cancer	0.000795	0.0029	CcSEcCtD
Dihydrocodeine—Headache—Etoposide—uterine cancer	0.00079	0.00289	CcSEcCtD
Dihydrocodeine—Vertigo—Epirubicin—uterine cancer	0.000778	0.00285	CcSEcCtD
Dihydrocodeine—Convulsion—Epirubicin—uterine cancer	0.000751	0.00274	CcSEcCtD
Dihydrocodeine—Nausea—Etoposide—uterine cancer	0.000749	0.00274	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000732	0.00268	CcSEcCtD
Dihydrocodeine—Dry mouth—Epirubicin—uterine cancer	0.000721	0.00264	CcSEcCtD
Dihydrocodeine—Vertigo—Doxorubicin—uterine cancer	0.00072	0.00263	CcSEcCtD
Dihydrocodeine—Confusional state—Epirubicin—uterine cancer	0.000713	0.00261	CcSEcCtD
Dihydrocodeine—Convulsion—Doxorubicin—uterine cancer	0.000695	0.00254	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Epirubicin—uterine cancer	0.000693	0.00253	CcSEcCtD
Dihydrocodeine—Skin disorder—Epirubicin—uterine cancer	0.000687	0.00251	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Epirubicin—uterine cancer	0.000684	0.0025	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000678	0.00248	CcSEcCtD
Dihydrocodeine—Dry mouth—Doxorubicin—uterine cancer	0.000667	0.00244	CcSEcCtD
Dihydrocodeine—Hypotension—Epirubicin—uterine cancer	0.000661	0.00241	CcSEcCtD
Dihydrocodeine—Confusional state—Doxorubicin—uterine cancer	0.00066	0.00241	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Doxorubicin—uterine cancer	0.000642	0.00235	CcSEcCtD
Dihydrocodeine—Skin disorder—Doxorubicin—uterine cancer	0.000635	0.00232	CcSEcCtD
Dihydrocodeine—Paraesthesia—Epirubicin—uterine cancer	0.000635	0.00232	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000632	0.00231	CcSEcCtD
Dihydrocodeine—Dyspnoea—Epirubicin—uterine cancer	0.00063	0.0023	CcSEcCtD
Dihydrocodeine—Somnolence—Epirubicin—uterine cancer	0.000629	0.0023	CcSEcCtD
Dihydrocodeine—Hypotension—Doxorubicin—uterine cancer	0.000611	0.00223	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00061	0.00223	CcSEcCtD
Dihydrocodeine—Constipation—Epirubicin—uterine cancer	0.000605	0.00221	CcSEcCtD
Dihydrocodeine—Paraesthesia—Doxorubicin—uterine cancer	0.000587	0.00215	CcSEcCtD
Dihydrocodeine—Dyspnoea—Doxorubicin—uterine cancer	0.000583	0.00213	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Epirubicin—uterine cancer	0.000583	0.00213	CcSEcCtD
Dihydrocodeine—Somnolence—Doxorubicin—uterine cancer	0.000582	0.00213	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000578	0.00211	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000565	0.00206	CcSEcCtD
Dihydrocodeine—Urticaria—Epirubicin—uterine cancer	0.000562	0.00205	CcSEcCtD
Dihydrocodeine—Constipation—Doxorubicin—uterine cancer	0.000559	0.00204	CcSEcCtD
Dihydrocodeine—Abdominal pain—Epirubicin—uterine cancer	0.000559	0.00204	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Doxorubicin—uterine cancer	0.000539	0.00197	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000535	0.00196	CcSEcCtD
Dihydrocodeine—Urticaria—Doxorubicin—uterine cancer	0.00052	0.0019	CcSEcCtD
Dihydrocodeine—Abdominal pain—Doxorubicin—uterine cancer	0.000517	0.00189	CcSEcCtD
Dihydrocodeine—Pruritus—Epirubicin—uterine cancer	0.0005	0.00183	CcSEcCtD
Dihydrocodeine—Diarrhoea—Epirubicin—uterine cancer	0.000484	0.00177	CcSEcCtD
Dihydrocodeine—Dizziness—Epirubicin—uterine cancer	0.000468	0.00171	CcSEcCtD
Dihydrocodeine—Pruritus—Doxorubicin—uterine cancer	0.000463	0.00169	CcSEcCtD
Dihydrocodeine—Vomiting—Epirubicin—uterine cancer	0.00045	0.00164	CcSEcCtD
Dihydrocodeine—Diarrhoea—Doxorubicin—uterine cancer	0.000448	0.00164	CcSEcCtD
Dihydrocodeine—Rash—Epirubicin—uterine cancer	0.000446	0.00163	CcSEcCtD
Dihydrocodeine—Dermatitis—Epirubicin—uterine cancer	0.000445	0.00163	CcSEcCtD
Dihydrocodeine—Headache—Epirubicin—uterine cancer	0.000443	0.00162	CcSEcCtD
Dihydrocodeine—Dizziness—Doxorubicin—uterine cancer	0.000433	0.00158	CcSEcCtD
Dihydrocodeine—Nausea—Epirubicin—uterine cancer	0.00042	0.00154	CcSEcCtD
Dihydrocodeine—Vomiting—Doxorubicin—uterine cancer	0.000416	0.00152	CcSEcCtD
Dihydrocodeine—Rash—Doxorubicin—uterine cancer	0.000412	0.00151	CcSEcCtD
Dihydrocodeine—Dermatitis—Doxorubicin—uterine cancer	0.000412	0.00151	CcSEcCtD
Dihydrocodeine—Headache—Doxorubicin—uterine cancer	0.00041	0.0015	CcSEcCtD
Dihydrocodeine—Nausea—Doxorubicin—uterine cancer	0.000389	0.00142	CcSEcCtD
